Precision Biosciences (DTIL) Return on Sales Growth (5y) (2023 - 2026)

Precision Biosciences (DTIL) Return on Sales Growth (5y) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,042.03 Bn 67,041.74 Bn -
2 Nanobiotix 1,908.00 Bn 1,907.94 Bn -
3 Akari Therapeutics 959.56 Bn 959.56 Bn -
4 BeOne Medicines 471.84 Bn 467.05 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.13 Bn 114.88 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.01 Bn 61.26 Bn 3.31 Bn
7 Belite Bio 62.34 Bn 62.34 Bn -
8 Argenx Se 55.93 Bn 50.74 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.49 Bn 34.48 Bn 959.66 Mn
10 Precision Biosciences 181.80 Mn 153.51 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00
Dec 31, 2025 3.00
Sep 30, 2025 -2,123.00
Jun 30, 2025 -1,199.00
Mar 31, 2025 -729.00
Dec 31, 2024 -34.00
Sep 30, 2024 -46.00
Jun 30, 2024 5.00
Mar 31, 2024 4.00
Dec 31, 2023 3.00
Sep 30, 2023 4.00
Jun 30, 2023 6.00
Mar 31, 2023 5.00